These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3902608)

  • 41. Hyperprolactinemia induced by pituitary isografts suppresses the priming effect of LH-releasing hormone in normal and hypogonadal mice.
    Lewis CE; Fink G; Dow RC; Morris JF
    Neuroendocrinology; 1986; 43(5):584-9. PubMed ID: 3528900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hyperprolactinemia. Reproductive consequences].
    Austin KL
    Rev Med Panama; 1989 Sep; 14(3):121-7. PubMed ID: 2813875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypothalamic Prolactin Regulation of Luteinizing Hormone Secretion in the Female Rat.
    Grachev P; Li XF; Goffin V; O'Byrne KT
    Endocrinology; 2015 Aug; 156(8):2880-92. PubMed ID: 25993525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
    Oseko F; Morikawa K; Motohashi T; Aso T
    Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gonadotropin-releasing hormone (GnRH) physiology in men and women.
    Santoro N; Filicori M; Spratt D; Crowley WF
    Acta Med Hung; 1986; 43(2):201-21. PubMed ID: 3295743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypothalamic luteinizing hormone releasing factor--physiology and clinical application].
    Bulkov I
    Akush Ginekol (Sofiia); 1976; 15(4):296-300. PubMed ID: 793434
    [No Abstract]   [Full Text] [Related]  

  • 48. Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone.
    Kalra SP; Crowley WR
    Front Neuroendocrinol; 1992 Jan; 13(1):1-46. PubMed ID: 1361458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
    Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
    J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of clinical backgrounds and pathogenesis of luteal-phase defect.
    Aisaka K; Yoshida K; Mori H
    Horm Res; 1992; 37 Suppl 1():41-7. PubMed ID: 1427628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of previous cooling of rat pituitaries on the release of GH, LH and prolactin in vitro.
    Uehara T; Arimura A; Schally AV
    Neuroendocrinology; 1973-1974; 13(4):278-83. PubMed ID: 4591852
    [No Abstract]   [Full Text] [Related]  

  • 52. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
    Santoro N; Wierman ME; Filicori M; Waldstreicher J; Crowley WF
    J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone.
    Beitins IZ; McArthur JW; Turnbull BA; Skrinar GS; Bullen BA
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1350-8. PubMed ID: 1902847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of hyperprolactinemia on prolactin and LH pulsatile pattern in female rats.
    Lafuente A; Marcó J; Esquifino AI
    Rev Esp Fisiol; 1992 Dec; 48(4):291-6. PubMed ID: 1302899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of rat prolactin on gonadotropin-releasing hormone secretion by the explanted male rat hypothalamus.
    Calogero AE; Weber RF; D'Agata R
    Neuroendocrinology; 1993 Jan; 57(1):152-8. PubMed ID: 8479610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperprolactinemia as a prognostic factor for menstrual disorders in female adolescents with advanced chronic kidney disease.
    Serret-Montaya J; Zurita-Cruz JN; Villasís-Keever MA; Aguilar-Kitsu A; Del Carmen Zepeda-Martinez C; Cruz-Anleu I; Hernández-Hernández BC; Alonso-Flores SR; Manuel-Apolinar L; Damasio-Santana L; Hernandez-Cabezza A; Romo-Vázquez JC
    Pediatr Nephrol; 2020 Jun; 35(6):1041-1049. PubMed ID: 32040631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproductive endocrine disorders in women with primary generalized epilepsy.
    Bilo L; Meo R; Nappi C; Annunziato L; Striano S; Colao AM; Merola B; Buscaino GA
    Epilepsia; 1988; 29(5):612-9. PubMed ID: 3044776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproductive correlates of chronic fatigue syndrome.
    Harlow BL; Signorello LB; Hall JE; Dailey C; Komaroff AL
    Am J Med; 1998 Sep; 105(3A):94S-99S. PubMed ID: 9790489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endocrine therapy of irregular uterine bleeding and amenorrhea.
    RANNEY B
    SD J Med Pharm; 1955 Jul; 8(7):213-24. PubMed ID: 13246789
    [No Abstract]   [Full Text] [Related]  

  • 60. [Endocrine diagnostic procedures and hormone treatment in male infertility (author's transl)].
    König MP
    Schweiz Rundsch Med Prax; 1980 Dec; 69(48):1794-7. PubMed ID: 7019878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.